Report Detail
Global Erectile Dysfunction Market Size, Status and Forecast 2019-2025
- RnM3402661 |
- 16 July, 2019 |
- Global |
- 101 Pages |
- QYResearch |
- Other
The loss of erection can be attributed to various factors such as high blood pressure, aging, diabetes mellitus, smoking, alcoholism, depression, nerve or spinal cord damage, and low testosterone levels.
The ED drugs segment led the market and accounted for almost 80% of the market share in terms of revenue.
In terms of geography, the Americas dominated the global erectile dysfunction market and is expected to hold close to 50% of the market share.
In 2018, the global Erectile Dysfunction market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Erectile Dysfunction status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Erectile Dysfunction development in United States, Europe and China.
The key players covered in this study
Eli Lilly
Pfizer
Bayer
Boston Scientific
Coloplast
Apricus Biosciences
Cristalia Produtos Quimicos Farmaceuticos
Dong-A Socio
Endo Pharmaceuticals
Futura Medical
Meda Pharmaceuticals
Promedon
SK Chemical
Teva Pharmaceuticals
Vivus
Zephyr Surgical Implants (ZSI)
Market segment by Type, the product can be split into
ED Drugs
ED Devices
Market segment by Application, split into
Congenital Patients
Pathological Patients
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Erectile Dysfunction status, future forecast, growth opportunity, key market and key players.
To present the Erectile Dysfunction development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Erectile Dysfunction are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Erectile Dysfunction Market Size Growth Rate by Type (2014-2025)
- 1.4.2 ED Drugs
- 1.4.3 ED Devices
- 1.5 Market by Application
- 1.5.1 Global Erectile Dysfunction Market Share by Application (2014-2025)
- 1.5.2 Congenital Patients
- 1.5.3 Pathological Patients
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Erectile Dysfunction Market Size
- 2.2 Erectile Dysfunction Growth Trends by Regions
- 2.2.1 Erectile Dysfunction Market Size by Regions (2014-2025)
- 2.2.2 Erectile Dysfunction Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
3 Market Share by Key Players
- 3.1 Erectile Dysfunction Market Size by Manufacturers
- 3.1.1 Global Erectile Dysfunction Revenue by Manufacturers (2014-2019)
- 3.1.2 Global Erectile Dysfunction Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global Erectile Dysfunction Market Concentration Ratio (CR5 and HHI)
- 3.2 Erectile Dysfunction Key Players Head office and Area Served
- 3.3 Key Players Erectile Dysfunction Product/Solution/Service
- 3.4 Date of Enter into Erectile Dysfunction Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Erectile Dysfunction Market Size by Type (2014-2019)
- 4.2 Global Erectile Dysfunction Market Size by Application (2014-2019)
5 United States
- 5.1 United States Erectile Dysfunction Market Size (2014-2019)
- 5.2 Erectile Dysfunction Key Players in United States
- 5.3 United States Erectile Dysfunction Market Size by Type
- 5.4 United States Erectile Dysfunction Market Size by Application
6 Europe
- 6.1 Europe Erectile Dysfunction Market Size (2014-2019)
- 6.2 Erectile Dysfunction Key Players in Europe
- 6.3 Europe Erectile Dysfunction Market Size by Type
- 6.4 Europe Erectile Dysfunction Market Size by Application
7 China
- 7.1 China Erectile Dysfunction Market Size (2014-2019)
- 7.2 Erectile Dysfunction Key Players in China
- 7.3 China Erectile Dysfunction Market Size by Type
- 7.4 China Erectile Dysfunction Market Size by Application
8 Japan
- 8.1 Japan Erectile Dysfunction Market Size (2014-2019)
- 8.2 Erectile Dysfunction Key Players in Japan
- 8.3 Japan Erectile Dysfunction Market Size by Type
- 8.4 Japan Erectile Dysfunction Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Erectile Dysfunction Market Size (2014-2019)
- 9.2 Erectile Dysfunction Key Players in Southeast Asia
- 9.3 Southeast Asia Erectile Dysfunction Market Size by Type
- 9.4 Southeast Asia Erectile Dysfunction Market Size by Application
10 India
- 10.1 India Erectile Dysfunction Market Size (2014-2019)
- 10.2 Erectile Dysfunction Key Players in India
- 10.3 India Erectile Dysfunction Market Size by Type
- 10.4 India Erectile Dysfunction Market Size by Application
11 Central & South America
- 11.1 Central & South America Erectile Dysfunction Market Size (2014-2019)
- 11.2 Erectile Dysfunction Key Players in Central & South America
- 11.3 Central & South America Erectile Dysfunction Market Size by Type
- 11.4 Central & South America Erectile Dysfunction Market Size by Application
12 International Players Profiles
- 12.1 Eli Lilly
- 12.1.1 Eli Lilly Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Erectile Dysfunction Introduction
- 12.1.4 Eli Lilly Revenue in Erectile Dysfunction Business (2014-2019)
- 12.1.5 Eli Lilly Recent Development
- 12.2 Pfizer
- 12.2.1 Pfizer Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Erectile Dysfunction Introduction
- 12.2.4 Pfizer Revenue in Erectile Dysfunction Business (2014-2019)
- 12.2.5 Pfizer Recent Development
- 12.3 Bayer
- 12.3.1 Bayer Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Erectile Dysfunction Introduction
- 12.3.4 Bayer Revenue in Erectile Dysfunction Business (2014-2019)
- 12.3.5 Bayer Recent Development
- 12.4 Boston Scientific
- 12.4.1 Boston Scientific Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Erectile Dysfunction Introduction
- 12.4.4 Boston Scientific Revenue in Erectile Dysfunction Business (2014-2019)
- 12.4.5 Boston Scientific Recent Development
- 12.5 Coloplast
- 12.5.1 Coloplast Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Erectile Dysfunction Introduction
- 12.5.4 Coloplast Revenue in Erectile Dysfunction Business (2014-2019)
- 12.5.5 Coloplast Recent Development
- 12.6 Apricus Biosciences
- 12.6.1 Apricus Biosciences Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Erectile Dysfunction Introduction
- 12.6.4 Apricus Biosciences Revenue in Erectile Dysfunction Business (2014-2019)
- 12.6.5 Apricus Biosciences Recent Development
- 12.7 Cristalia Produtos Quimicos Farmaceuticos
- 12.7.1 Cristalia Produtos Quimicos Farmaceuticos Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Erectile Dysfunction Introduction
- 12.7.4 Cristalia Produtos Quimicos Farmaceuticos Revenue in Erectile Dysfunction Business (2014-2019)
- 12.7.5 Cristalia Produtos Quimicos Farmaceuticos Recent Development
- 12.8 Dong-A Socio
- 12.8.1 Dong-A Socio Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Erectile Dysfunction Introduction
- 12.8.4 Dong-A Socio Revenue in Erectile Dysfunction Business (2014-2019)
- 12.8.5 Dong-A Socio Recent Development
- 12.9 Endo Pharmaceuticals
- 12.9.1 Endo Pharmaceuticals Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Erectile Dysfunction Introduction
- 12.9.4 Endo Pharmaceuticals Revenue in Erectile Dysfunction Business (2014-2019)
- 12.9.5 Endo Pharmaceuticals Recent Development
- 12.10 Futura Medical
- 12.10.1 Futura Medical Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Erectile Dysfunction Introduction
- 12.10.4 Futura Medical Revenue in Erectile Dysfunction Business (2014-2019)
- 12.10.5 Futura Medical Recent Development
- 12.11 Meda Pharmaceuticals
- 12.12 Promedon
- 12.13 SK Chemical
- 12.14 Teva Pharmaceuticals
- 12.15 Vivus
- 12.16 Zephyr Surgical Implants (ZSI)
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Erectile Dysfunction . Industry analysis & Market Report on Erectile Dysfunction is a syndicated market report, published as Global Erectile Dysfunction Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Erectile Dysfunction market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
